Olaparib

Target: This ligand targets poly(ADP-ribose) polymerases PARP1 and PARP2 in biochemical or cellular target-engagement studies.

Mechanism of Action: Used as the target-protein recognition element, this ligand provides the binding interface for poly(ADP-ribose) polymerases PARP1 and PARP2. In PROTAC design, a derivatizable position on the ligand can be connected through an optimized linker to an E3 ligase ligand, such as a CRBN, VHL, or IAP recruiter, while preserving productive target engagement. The resulting bifunctional molecule brings poly(ADP-ribose) polymerases PARP1 into proximity with the recruited E3 ligase, enabling ternary-complex formation. If the complex has favorable geometry and residence time, target lysine ubiquitination is promoted, leading to proteasome-dependent degradation in experimental systems.

• PARP1/2 DEGRADATION PROTACs: Olaparib is a PARP inhibitor ligand commonly used as a targeting moiety in PROTAC designs to recruit E3 ligases toward PARP1 and PARP2. By converting binding into ubiquitination, these constructs aim to trigger proteasomal degradation, enabling functional studies of PARP-dependent pathways beyond catalytic inhibition.

• DNA DAMAGE RESPONSE STUDIES: PROTACs built with Olaparib can be used to dissect how PARP1/2 removal reshapes DNA damage signaling, repair pathway choice, and replication stress responses. Degradation-based perturbation helps distinguish loss of PARP scaffolding and substrate interactions from inhibition-only phenotypes, improving mechanistic interpretation in cellular assays.

• SELECTIVE PATHWAY DISSECTION: Using Olaparib as a ligand in targeted degradation strategies supports comparative analyses across PARP family members and PARP1/2-dependent substrates. Researchers can tune linker length and E3 recruitment to evaluate degradation selectivity, quantify knockdown kinetics, and correlate residual PARP activity with downstream biomarker changes.

• RESISTANCE MECHANISM EXPLORATION: Olaparib-based PROTACs provide a tool to probe resistance to PARP inhibition by targeting PARP proteins for elimination rather than active-site blockade. This approach can clarify whether resistant phenotypes arise from altered PARP abundance, compensatory signaling, or changes in ubiquitination and proteasome dependence.

• PROTEASOME DEPENDENCE VALIDATION: Olaparib-derived PROTACs are useful for establishing degradation mechanisms through proteasome and ubiquitination dependency experiments. Researchers can assess PARP1/2 turnover upon E3 engagement, use pathway inhibitors to confirm ubiquitin-proteasome involvement, and map degradation kinetics to guide optimization of PROTAC architecture.

Olaparib is a PARP target ligand intended for use as the target-engaging component or reference ligand in PROTAC discovery workflows. Its known small-molecule recognition profile enables rational linker-vector evaluation and comparative degrader design. This molecule is described in detail below.

Structure: The structure of Olaparib is characterized by primary or secondary amine/basic nitrogen centers; halogenated aryl/heteroaryl ring system. These features provide defined hydrogen-bonding, hydrophobic, and steric elements that can support affinity retention while enabling analogue-based linker-vector selection.

Reactivity: The amine/basic nitrogen-containing motif can be evaluated for acylation, sulfonylation, alkylation, or carbamate/urea linker installation when that vector is solvent exposed. For PROTAC construction, the POI ligand can be paired with CRBN ligands such as thalidomide, pomalidomide, or lenalidomide analogues, VHL ligands such as VH032 derivatives, or less common IAP/MDM2/cIAP-recruiting ligands, with alkyl, PEG, piperazine, triazole, or amide linkers screened for ternary-complex formation. In practice, incorporation into PROTACs should begin from derivatives that preserve the reported binding pharmacophore, followed by systematic variation of linker length, polarity, rigidity, and exit-vector geometry to optimize target engagement, E3 recruitment, and cellular degradation readouts.